Skip to main content
Clinical Trials/NCT04459143
NCT04459143
Completed
Not Applicable

Chronic Obstructive Pulmonary Disease (COPD) and Advance Directives

Hôpital NOVO1 site in 1 country525 target enrollmentMay 16, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Obstructive Pulmonary Disease
Sponsor
Hôpital NOVO
Enrollment
525
Locations
1
Primary Endpoint
Number of patient who write their advance directives
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The aim of this study is to evaluate if the participation of COPD patients to a workshop on advance directives increases the number of patients who write them.

Detailed Description

Chronic Obstructive Disease is a common disease and should be the third leading cause of death in 2020. Patient hospitalized for an exacerbation of their COPD have a median survival of 2 years and 50% risk of being rehospitalized within 6 months. COPD patients may have symptoms that impair their life quality significantly and sometimes more than patients with cancer. This is particularly the case for dyspnea, which is frequently present. In the study, Investigators propose the setting up of health workshop on advance directives. This workshop is for sever or very severe COPD patients during their hospital stay in the post-acute care and pulmonary rehabilitation service. In this unit, investigators welcome patient from all the region of Ile de France for a hospital stay of approximately 6 weeks. A first workshop will take place during the third week of their care to inform them about COPD, exacerbations, prognostic and advance directives. Then, a personal interview with patients who have participated to this workshop will take place to collect their advance directives and their degree of satisfaction about this process.

Registry
clinicaltrials.gov
Start Date
May 16, 2019
End Date
October 31, 2020
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Hôpital NOVO
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • COPD Gold 3 or 4 and Curtis criteria

Exclusion Criteria

  • left to the discretion of the investigator if he finds that it will not be beneficial for the patient : for example if the workshop is judged to be at risk of being anxiety-provoking

Outcomes

Primary Outcomes

Number of patient who write their advance directives

Time Frame: At the end of patient hospital stay, approximately 6 weeks

The Primary Outcome Measure is the collect of the number of patients who write their advance directives after their participation of the health workshop

Secondary Outcomes

  • Measure of patient's satisfaction(At the end of patient hospital stay, approximately 6 weeks)

Study Sites (1)

Loading locations...

Similar Trials